Signs of Amyloidosis You Should Look Out For

Amyloidosis is an uncommon disease that occurs when abnormal proteins accumulate in the body’s organs and tissues, disrupting their normal function. Understanding how it is identified, exploring current treatment approaches, and recognizing the importance of timely diagnosis can help improve health outcomes and preserve quality of life.

Signs of Amyloidosis You Should Look Out For

What Is Amyloidosis and How Does It Develop?

Amyloidosis occurs when misfolded proteins begin to aggregate and accumulate in tissues and organs. In healthy individuals, proteins typically fold into specific three-dimensional shapes that allow them to perform their intended functions. When proteins misfold and combine with other identical misfolded proteins, they form amyloid fibrils that can deposit in various parts of the body.

There are several types of amyloidosis, each characterized by the specific protein that misfolds:

  • AL (light chain) amyloidosis: The most common form in developed countries, caused by abnormal plasma cells in the bone marrow producing misfolded light chain proteins

  • AA amyloidosis: Associated with chronic inflammatory or infectious diseases

  • ATTR amyloidosis: Results from misfolding of the transthyretin protein, which can be either hereditary or age-related

  • Dialysis-related amyloidosis: Occurs in patients with long-term kidney dialysis

The development of amyloidosis is often gradual, with protein deposits accumulating over time until they reach levels that begin to interfere with organ function. This slow progression can make early detection challenging, as symptoms may not appear until significant damage has occurred.

What Are the Symptoms and How Is Amyloidosis Diagnosed Early?

The signs and symptoms of amyloidosis can vary widely depending on which organs are affected by the protein deposits. Common warning signs include:

  • Unexplained weight loss

  • Persistent fatigue and weakness

  • Swelling in the ankles and legs (edema)

  • Shortness of breath, even with minimal exertion

  • Numbness, tingling, or pain in the hands and feet (peripheral neuropathy)

  • Enlarged tongue (macroglossia)

  • Skin changes, including easy bruising and purpura (purple patches)

  • Irregular heartbeat and heart problems

  • Diarrhea, constipation, or alternating between the two

  • Dizziness upon standing (orthostatic hypotension)

  • Carpal tunnel syndrome

If amyloidosis is suspected, the diagnostic process typically involves:

  1. Medical history review and physical examination

  2. Blood and urine tests to check for abnormal proteins

  3. Tissue biopsy, considered the gold standard for diagnosis, where a small sample is examined for amyloid deposits

  4. Specialized imaging tests such as echocardiogram, MRI, or nuclear medicine scans

  5. Genetic testing for hereditary forms of the disease

Early diagnosis is crucial, as it allows for treatment before irreversible organ damage occurs. Unfortunately, because the symptoms can mimic many other conditions, amyloidosis is often not diagnosed until it has advanced.

What Are the Current Treatment Options and Medications for Amyloidosis?

Treatment for amyloidosis aims to reduce the production of amyloid proteins, manage symptoms, and support affected organs. The specific approach depends on the type of amyloidosis and organs involved:

For AL amyloidosis:

  • Chemotherapy agents to target abnormal plasma cells

  • Autologous stem cell transplantation for eligible patients

  • Proteasome inhibitors like bortezomib (Velcade)

  • Immunomodulatory drugs such as lenalidomide or pomalidomide

  • Monoclonal antibodies like daratumumab

For ATTR amyloidosis:

  • TTR stabilizers like tafamidis and diflunisal

  • RNA-targeting therapies including patisiran and inotersen

  • Liver transplantation (for hereditary ATTR)

For AA amyloidosis:

  • Treatment of the underlying inflammatory condition

  • Anti-inflammatory medications

  • Biologics targeting specific inflammatory pathways

Recent advances in treatment have significantly improved outcomes for many patients, particularly for AL and ATTR amyloidosis, where newer medications can effectively slow or halt disease progression when started early.

As amyloid proteins deposit in organs, they can cause a range of complications that require specific management approaches:

Heart involvement:

  • Diuretics for fluid retention

  • Blood pressure medications

  • Pacemaker implantation if electrical conduction is affected

  • Careful monitoring for heart failure

  • Heart transplantation in select cases

Kidney involvement:

  • Blood pressure control

  • Dietary modifications

  • Medications to reduce protein in urine

  • Dialysis for advanced kidney disease

  • Kidney transplantation when appropriate

Nervous system involvement:

  • Pain management for neuropathy

  • Physical therapy

  • Medications for autonomic symptoms

  • Supportive devices for mobility

Gastrointestinal involvement:

  • Nutritional support

  • Anti-diarrheal medications

  • Prokinetic agents for motility issues

  • Modified diet recommendations

The management of organ complications requires a multidisciplinary approach, with specialists from cardiology, nephrology, neurology, and gastroenterology often working together to provide comprehensive care.

What Does Living with Amyloidosis Long Term Involve?

Living with amyloidosis long-term requires ongoing medical care, lifestyle adjustments, and careful monitoring:

Regular follow-up with healthcare providers is essential for:

  • Monitoring disease progression

  • Adjusting treatments as needed

  • Screening for new complications

  • Assessing response to therapies

Lifestyle considerations may include:

  • Modified physical activity based on capabilities

  • Dietary adjustments, particularly sodium restriction for cardiac involvement

  • Careful management of fluid intake

  • Energy conservation strategies for fatigue

  • Supportive care for symptom management

Support resources are crucial, including:

  • Patient support groups

  • Mental health services

  • Physical and occupational therapy

  • Social services for assistance with daily living

The prognosis for amyloidosis has improved significantly with newer treatments. Many patients who receive early diagnosis and appropriate treatment can maintain good quality of life and experience disease stabilization or improvement. The most important factor affecting long-term outcomes is how early the disease is detected and treated, underscoring the importance of recognizing the early signs.

This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.